JMP Securities Reaffirms “Market Perform” Rating for Cross Country Healthcare (NASDAQ:CCRN)

Cross Country Healthcare (NASDAQ:CCRNGet Free Report)‘s stock had its “market perform” rating reaffirmed by stock analysts at JMP Securities in a research report issued to clients and investors on Thursday,Benzinga reports.

Several other research analysts also recently commented on CCRN. Benchmark downgraded shares of Cross Country Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, December 4th. Barrington Research reiterated a “market perform” rating on shares of Cross Country Healthcare in a research report on Tuesday, December 10th. StockNews.com initiated coverage on shares of Cross Country Healthcare in a research report on Friday, January 31st. They set a “hold” rating for the company. Truist Financial lifted their price objective on Cross Country Healthcare from $15.00 to $18.61 and gave the stock a “hold” rating in a report on Thursday, December 5th. Finally, William Blair cut Cross Country Healthcare from a “strong-buy” rating to a “hold” rating in a report on Wednesday, December 4th. Six research analysts have rated the stock with a hold rating, Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $18.54.

Check Out Our Latest Research Report on CCRN

Cross Country Healthcare Trading Down 0.1 %

CCRN opened at $18.18 on Thursday. The stock has a market capitalization of $596.67 million, a P/E ratio of -363.53, a PEG ratio of 3.35 and a beta of 0.44. The stock has a 50-day moving average price of $17.70 and a 200-day moving average price of $14.89. Cross Country Healthcare has a 12-month low of $9.58 and a 12-month high of $21.41.

Institutional Trading of Cross Country Healthcare

Several large investors have recently modified their holdings of CCRN. Jane Street Group LLC lifted its holdings in Cross Country Healthcare by 337.6% in the 3rd quarter. Jane Street Group LLC now owns 181,492 shares of the business services provider’s stock worth $2,439,000 after buying an additional 140,013 shares during the period. PDT Partners LLC purchased a new stake in Cross Country Healthcare in the third quarter worth $856,000. Barclays PLC boosted its holdings in Cross Country Healthcare by 117.5% in the third quarter. Barclays PLC now owns 80,277 shares of the business services provider’s stock valued at $1,078,000 after acquiring an additional 43,372 shares in the last quarter. Royce & Associates LP increased its position in Cross Country Healthcare by 51.4% during the 3rd quarter. Royce & Associates LP now owns 1,132,566 shares of the business services provider’s stock valued at $15,222,000 after purchasing an additional 384,374 shares during the period. Finally, Systematic Financial Management LP raised its holdings in Cross Country Healthcare by 8.5% in the 3rd quarter. Systematic Financial Management LP now owns 1,662,730 shares of the business services provider’s stock worth $22,347,000 after purchasing an additional 130,746 shares in the last quarter. 96.03% of the stock is owned by institutional investors.

About Cross Country Healthcare

(Get Free Report)

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company’s Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.

Read More

Analyst Recommendations for Cross Country Healthcare (NASDAQ:CCRN)

Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.